Gestational diabetes mellitus is the most common endocrine disorder in pregnancy and a cause of maternal and fetal morbidities and mortalities. The oral glucose tolerance test is the gold standard for diagnosing gestational diabetes mellitus. Nevertheless, the oral glucose tolerance test is time-consuming and requires patient preparation. On the contrary, Glycated albumin does not require patient preparation or administration of any substance. Most studies on glycated albumin in pregnancy were among the non-African population, and black Americans have higher glycated albumin levels than Caucasians. This study determined the use of glycated albumin in diagnosing gestational diabetes mellitus among pregnant women. The study was a prospective study of 160 pregnant women between 24 and 28 weeks of gestation at the University of Port Harcourt Teaching Hospital. The diagnosis of gestational diabetes mellitus was based on the World Health Organization 2013 criteria. The diagnostic value of glycated albumin was determined using the area under the receiver operator characteristic curve. The prevalence of gestational diabetes mellitus was 9.4% and the mean glycated albumin was 16.91% (±2.77). The area under the receiver operator characteristic curve for glycated albumin was 0.845 (95% CI 0.733 - 0.956; p = 0.0001). The optimal cut-off value of glycated albumin in the diagnosis of gestational diabetes mellitus was 18.9%. Glycated albumin was useful in the diagnosis of gestational diabetes mellitus at 24 to 28 weeks of gestation.
References
[1]
Chong, H.P., Alazzani, H. and Boelaert, K. (2019) Endocrine Disorders in Pregnancy. Obstetrics, Gynaecology and Reproductive Medicine, 29, 301-305. https://doi.org/10.1016/j.ogrm.2019.08.005
[2]
International Diabetes Federation (2021) Diabetes Atlas. https://www.diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf
[3]
World Health Organization. (2013) Diagnostic Criteria and Classification of Hyperglycemia First Detected in Pregnancy. http://apps.who.int/iris/bitstream/10665/85975/1/WHO_NMH_MND_13.2_eng.pdf
[4]
Muche, A.A., Olayemi, O.O. and Gete, Y.K. (2019) Prevalence and Determinants of Gestational Diabetes Mellitus in Africa Based on the Updated International Diagnostic Criteria: A Systematic Review and Meta-Analysis. Archives of Public Health, 77, Article No. 36. https://doi.org/10.1186/s13690-019-0362-0
[5]
Behboudi-Gandevani, S., Amiri, M., Yarandi, R.B. and Tehrani, F.R. (2019) The Impact of Diagnostic Criteria for Gestational Diabetes on Its Prevalence: A Systematic Review and Meta-Analysis. Diabetology & Metabolic Syndrome, 11, Article No. 11. https://doi.org/10.1186/s13098-019-0406-1
[6]
Eades, C.E., Cameron, D.M. and Evans, J.M.M. (2017) Prevalence of Gestational Diabetes Mellitus in Europe: A Meta-Analysis. Diabetes Research and Clinical Practice, 129, 173-181. https://doi.org/10.1016/j.diabres.2017.03.030
[7]
John, D.H., Awoyesuku, P.A., MacPepple, D.A. and Kwosah, N.J. (2019) Prevalence of Gestational Diabetes Mellitus and Maternal and Fetal Outcomes at the Rivers State University Teaching Hospital (RSUTH), Port Harcourt, Nigeria. Journal of Advances in Medicine and Medical Research, 31, 1-16. https://doi.org/10.9734/jammr/2019/v31i930319
National Institute for Health and Care Excellence (2020) Diabetes in Pregnancy: Management from Preconception to the Postnatal Period. https://nice.org.uk/guidance/ng3
[10]
Billionnet, C., Mitanchez, D., Weill, A., Nizard, J., Alla, F., Hartemann, A., et al. (2017) Gestational Diabetes and Adverse Perinatal Outcomes from 716,152 Births in France in 2012. Diabetologia, 60, 636-644. https://doi.org/10.1007/s00125-017-4206-6
[11]
Battarbee, A.N., Venkatesh, K.K., Aliaga, S. and Boggess, K.A. (2020) The Association of Pregestational and Gestational Diabetes with Severe Neonatal Morbidity and Mortality. Journal of Perinatology, 40, 232-239. https://doi.org/10.1038/s41372-019-0516-5
[12]
Sathiamma, P.K. and Lalithambica, K.A. (2017) Prospective Study on Maternal and Perinatal Outcome of Gestational Diabetes Mellitus. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 6, 2933-2938. https://doi.org/10.18203/2320-1770.ijrcog20172910
[13]
Bianco, M.E. and Josefson, J.L. (2019) Hyperglycemia during Preg-nancy and Long-Term Offspring Outcomes. Current Diabetes Reports, 19, Article No. 143. https://doi.org/10.1007/s11892-019-1267-6
[14]
Farahvar, S., Walfisch, A. and Sheiner E. (2019) Gestational Diabetes Risk Factors and Long-Term Consequences for Both Mother and Offspring: A Literature Review. Expert Review of Endocrinology & Metabolism, 14, 63-74. https://doi.org/10.1080/17446651.2018.1476135
[15]
Muche, A.A., Olayemi, O.O. and Gete, Y.K. (2020) Effects of Gestational Diabetes Mellitus on Risk of Adverse Maternal Outcomes: A Prospective Cohort Study in Northwest Ethiopia. BMC Pregnancy and Childbirth, 20, Article No. 73. https://doi.org/10.1186/s12884-020-2759-8
[16]
Hod, M., Kapur, A., Sacks, D.A., Hadar, E., Agarwal, M., Di Renzo, G.C., et al. (2015) The International Federation of Gynecology and Obstetrics (FIGO) Initiative on Gestational Diabetes Mellitus: A Pragmatic Guide for Diagnosis, Management, and Care. International Journal of Gynecology & Obstetrics, 131, S173-S211. https://doi.org/10.1016/S0020-7292(15)30007-2
[17]
Hymavathi, K., Tadisetti, S., Polisetty, K. and Gottipatti, M.D. (2016) Gestational Diabetes Mellitus-Universal versus Selective Screening. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 5, 2155-2160. https://doi.org/10.18203/2320-1770.ijrcog20162083
[18]
Jagannathan, R., Neves, J.S., Dorcely, B., Chung, S.T., Tamura, K. and Rhee, M. (2020) The Oral Glucose Tolerance Test: 100 Years Later. Diabetes, Metabolic Syndrome and Obesity, 13, 3787-3805. https://doi.org/10.2147/DMSO.S246062
[19]
Bogdanet, D., O’Shea, P., Lyons, C., Shafat, A. and Dunne, F. (2020) The Oral Glucose Tolerance Test—Is It Time for a Change?—A Literature Review with an Emphasis on Pregnancy. Journal of Clinical Medicine, 9, Article 3451. https://doi.org/10.3390/jcm9113451
[20]
Nanda, R., Patel, S., Sahoo, S. and Mohapatra, E. (2018) Review of Pre-Analytical Errors in Oral Glucose Tolerance Testing in a Tertiary Care Hospital. Journal of Nepal Health Research Council, 16, 6-10. https://doi.org/10.3126/jnhrc.v16i1.19353
[21]
Ceriello, A., Monnier, L. and Owens, D. (2019) Glycaemic Variability in Diabetes: Clinical and Therapeutic Implications. The Lancet Diabetes and Endocrinology, 7, 221-230. https://doi.org/10.1016/S2213-8587(18)30136-0
[22]
Agarwal, M.M., Punnose, J. and Dhatt, G.S. (2004) Gestational Diabetes: Problems Associated with the Oral Glucose Tolerance Test. Diabetes Research and Clinical Practice, 63, 73-74. https://doi.org/10.1016/j.diabres.2003.08.005
[23]
Freitas, P.A.C., Ehlert, L.R. and Camargo, J.L. (2017) Glycated Albumin: A Potential Biomarker in Diabetes. Archives of Endocrinology and Metabolism, 61, 296-304. https://doi.org/10.1590/2359-3997000000272
[24]
Piuri, G., Basello, K., Rossi, G., Soldavini, C.M, Duiella, S., Privitera, G., et al. (2020) Methylglyoxal, Glycated Albumin, PAF, and TNF- Possible Inflammatory and Metabolic Biomarkers for Management of Gestational Diabetes. Nutrients, 12, Article 479. https://doi.org/10.3390/nu12020479
[25]
Li, P., Lin, S., Li, L., Cui, J., Zhou, S. and Fan, J. (2019) First-Trimester Fasting Plasma Glucose as a Predictor of Gestational Diabetes Mellitus and the Association with Adverse Pregnancy Outcomes. Pakistan Journal of Medical Sciences, 35, 95-100. https://doi.org/10.12669/pjms.35.1.216
[26]
Agarwal, M.M. (2016) Gestational Diabetes Mellitus: Screening with Fasting Plasma Glucose. World Journal of Diabetes, 7, 279-289. https://doi.org/10.4239/wjd.v7.i14.279
Dozio, E., Di Gaetano, N., Findeisen, P. and Corsi, R.M.M. (2017) Glycated Albumin: From Biochemistry and Laboratory Medicine to Clinical Practice. Endocrine, 55, 682-690. https://doi.org/10.1007/s12020-016-1091-6
[29]
George, J.A. and Erasmus, R.T. (2018) Haemoglobin A1c or Glycated Albumin for Diagnosis and Monitoring Diabetes: An African Perspective. Indian Journal of Clinical Biochemistry, 33, 255-261. https://doi.org/10.1007/s12291-018-0755-9
[30]
Brede, C., Hop, B., Jorgensen, K. and Skadberg, O. (2016) Measurement of Glycated Albumin in Serum and Plasma by LC-MS/MS. Scandinavian Journal of Clinical and Laboratory Investigation, 76, 195-201. https://doi.org/10.3109/00365513.2015.1129671
[31]
Huang, Y., Hu, Y., Ma, Y. and Ye, G. (2015) Glycated Albumin Is an Optimal Biomarker for Gestational Diabetes Mellitus. Experimental and Therapeutic Medicine, 10, 2145-2149. https://doi.org/10.3892/etm.2015.2808
[32]
Li, H., Wang, F., Tao, M., Huang, Y. and Jia, W. (2016) Association between Glycemic Control and Birthweight with Glycated Albumin in Chinese Women with Gestational Diabetes Mellitus. Journal of Diabetes Investigation, 7, 48-55. https://doi.org/10.1111/jdi.12383
[33]
Selvin, E., Steffes, M.W., Ballantyne, C.M., Hoogeveen, R.C., Coresh, J. and Brancati, F.L. (2011) Racial Differences in Glycemic Markers: A Cross-Sectional Analysis of Community-Based Data. Annals of Internal Medicine, 154, 303-309. https://doi.org/10.7326/0003-4819-154-5-201103010-00004
[34]
Trevethan, R. (2017) Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice. Frontiers in Public Health, 5, Article 307. https://doi.org/10.3389/fpubh.2017.00307
[35]
Zhu, J., Chen, Y., Li, C., Tao, M. and Teng, Y. (2018) The Diagnostic Value of Glycated Albumin in Gestational Diabetes Mellitus. Journal of Endocrinological Investigation, 41, 121-128. https://doi.org/10.1007/s40618-016-0605-7
